U.S. federal trademark · Serial No. 88827351 · Reg. No. 7249621
Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the treatment of cancer, autoimmune, immune mediated, immune system related, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the prevention and treatment of viral and infectious diseases; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for therapeutic vaccines
Scientific research in the fields of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.